Atlas Trials

Safety and Efficacy on Phase III Study on 300 IR SLIT to Patients Suffering From Grass Pollen Rhinoconjunctivitis

Clinical trial NCT00803244 · COMPLETED

Trial details

NCT number
NCT00803244
Sponsor
Stallergenes Greer
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Primary Disease
Start date
2009-01-01
Primary completion
2009-08-01
Enrollment
381

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.